Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.

× No keyword cloud information.

10 in total

Review 1. Tumor-induced osteomalacia.

Authors: M K Drezner
Journal: Rev Endocr Metab Disord Date: 2001-04 Impact factor: 6.514

2. Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation.

Authors: Emily G Farrow; Lelia J Summers; Susan C Schiavi; James A McCormick; David H Ellison; Kenneth E White
Journal: J Endocrinol Date: 2010-07-30 Impact factor: 4.286

3. Approach to the hypophosphatemic patient.

Authors: Erik A Imel; Michael J Econs
Journal: J Clin Endocrinol Metab Date: 2012-03 Impact factor: 5.958

4. Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

Authors: Peter S N Rowe; Naoko Matsumoto; Oak D Jo; Remi N J Shih; Jeannine Oconnor; Martine P Roudier; Steve Bain; Shiguang Liu; Jody Harrison; Norimoto Yanagawa
Journal: Bone Date: 2006-06-09 Impact factor: 4.398

5. Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP.

Authors: Aline Martin; Valentin David; Jennifer S Laurence; Patricia M Schwarz; Eileen M Lafer; Anne-Marie Hedge; Peter S N Rowe
Journal: Endocrinology Date: 2007-12-27 Impact factor: 4.736

6. Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype.

Authors: Baozhi Yuan; Jian Q Feng; Stephen Bowman; Ying Liu; Robert D Blank; Iris Lindberg; Marc K Drezner
Journal: J Bone Miner Res Date: 2013-01 Impact factor: 6.741

7. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.

Authors: R M Harrell; K W Lyles; J M Harrelson; N E Friedman; M K Drezner
Journal: J Clin Invest Date: 1985-06 Impact factor: 14.808

8. Characteristics of phosphate transport in osteoblastlike cells.

Authors: J Caverzasio; T Selz; J P Bonjour
Journal: Calcif Tissue Int Date: 1988-08 Impact factor: 4.333

9. Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.

Authors: L D Quarles; V W Dennis; H J Gitelman; J M Harrelson; M K Drezner
Journal: J Clin Invest Date: 1985-05 Impact factor: 14.808

Review 10. Therapeutics of X-linked hypophosphatemic rickets.

Authors: K Latta; S Hisano; J C Chan
Journal: Pediatr Nephrol Date: 1993-12 Impact factor: 3.714

10 in total